Post Test and Evaluation for "Beyond the Opioid Epidemic - The Impact of Opioids on Pregnancy and Nursing Care" (Virtual) Presented by: Dr. Oliver Grundmann
“This activity is approved for 0.5 contact hour(s) of continuing education (which includes 3.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 17102866. This activity was planned in accordance with AANP CE Standards and Policies.”
Email address *
First Name
1 point
Your answer
Last Name *
1 point
Your answer
Discipline (Pick at least one) *
1 point
Required
Which of the following describes you? *
1 point
Required
1. Which synthetic derivative of morphine has about 80 times the potency and has in recent years contributed to the opioid overdose epidemic? *
1 point
2. Which of the following is usually absent in patients presenting with the opioid toxidrome? *
1 point
3. Which clinical symptom of the opioid toxidrome is of grave concern and requires immediate attention? *
1 point
4. What is the usual initial dose of naloxone to reverse respiratory depression in infants under the age of 5 or weighing less than 20 kg? *
1 point
5. All of the following are classified as opioid receptors except for: *
1 point
6. Upon binding of morphine to opioid receptors, which neurotransmitter is released in higher amounts into the synaptic cleft? *
1 point
7. What is the NAS threshold score after consecutive measures for transferring a newborn to the NICU? *
1 point
8. In newborns with NAS scores above 9, what dose of morphine sulfate is used initially to treat withdrawal symptoms? *
1 point
9. Methadone is used for newborns with NAS in outpatient treatment. If the newborn did not require methadone for the past 48 hours, by how much should the last dose be reduced? *
1 point
10. Which model supports a mother with an opioid use disorder during her pregnancy while not seeking to punish her? *
1 point
11. As a result of my participation in this activity, I am better able to interpret the symptoms of the opioid toxidrome and take appropriate steps to stabilize a patient. *
Strongly Agree
Strongly Disagree
12. As a result of my participation in this activity, I am better able to relate the symptoms of neonatal withdrawal syndrome to the effects of the mechanism of opioids. *
1 point
Strongly Agree
Strongly Disagree
13. As a result of this activity, I have a greater understanding of ways to develop treatment approaches based on the NAS score in conjunction with the healthcare team. *
1 point
Strongly Agree
Strongly Disagree
14. As a result of this activity, I can contrast current and future approaches to prevention of NAS and opioid use during pregnancy. *
1 point
Strongly Agree
Strongly Disagree
15. The speaker (Dr. Oliver Grundmann) demonstrated experiential knowledge of the topic. *
1 point
Strongly Agree
Strongly Disagree
16. The individual objectives /content topics were cohesive with one another. *
1 point
Strongly Agree
Strongly Disagree
17. The content provided a fair and balanced coverage of the topic. *
1 point
Strongly Agree
Strongly Disagree
18. Speaker (Dr. Oliver Grundmann) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at the beginner of, or during the presentation. *
1 point
Strongly Agree
Strongly Disagree
19. The content was free of commercial bias. *
1 point
Strongly Agree
Strongly Disagree
20. I would recommend this activity to my colleagues. *
1 point
Strongly Agree
Strongly Disagree
21. What, if any, recommendations would you like to share for future improvement of this program? *
1 point
Your answer
This program has been sponsored by the Frontier Nursing University Alumni Association
Submit
Never submit passwords through Google Forms.
This form was created inside of Frontier Nursing University. Report Abuse - Terms of Service